These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8026983)

  • 1. HLA-A2-binding peptides cross-react not only within the A2 subgroup but also with other HLA-A-locus allelic products.
    Tanigaki N; Fruci D; Chersi A; Falasca G; Tosi R; Butler RH
    Hum Immunol; 1994 Mar; 39(3):155-62. PubMed ID: 8026983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anchor residue motifs of HLA class-I-binding peptides analyzed by the direct binding of synthetic peptides to HLA class I alpha chains.
    Fruci D; Rovero P; Falasca G; Chersi A; Sorrentino R; Butler R; Tanigaki N; Tosi R
    Hum Immunol; 1993 Nov; 38(3):187-92. PubMed ID: 8106276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I binding of synthetic nonamer peptides carrying major anchor residue motifs of HLA-B27 (B*2705)-binding peptides.
    Fruci D; Rovero P; Butler RH; Sorrentino R; Tosi R; Tanigaki N
    Immunogenetics; 1993; 38(1):41-6. PubMed ID: 8462993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of the serologically defined HLA-Aw19 antigens. A genetically distinct family of HLA-A antigens comprising A29, A31, A32, and Aw33, but probably not A30.
    Kato K; Trapani JA; Allopenna J; Dupont B; Yang SY
    J Immunol; 1989 Nov; 143(10):3371-8. PubMed ID: 2478623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-A2 subtypes are functionally distinct in peptide binding and presentation.
    Barouch D; Friede T; Stevanović S; Tussey L; Smith K; Rowland-Jones S; Braud V; McMichael A; Rammensee HG
    J Exp Med; 1995 Dec; 182(6):1847-56. PubMed ID: 7500030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1.
    Stuber G; Dillner J; Modrow S; Wolf H; Székely L; Klein G; Klein E
    Int Immunol; 1995 Apr; 7(4):653-63. PubMed ID: 7547693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires.
    Sidney J; Southwood S; Sette A
    Immunogenetics; 2005 Jul; 57(6):393-408. PubMed ID: 16003466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring myelin basic protein for HLA class I-binding sequences.
    Tanigaki N; Fruci D; Groome N; Butler RH; Londei M; Tosi R
    Eur J Immunol; 1994 Sep; 24(9):2196-202. PubMed ID: 7522167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition of specific peptide motifs for four major HLA-A alleles.
    Kubo RT; Sette A; Grey HM; Appella E; Sakaguchi K; Zhu NZ; Arnott D; Sherman N; Shabanowitz J; Michel H
    J Immunol; 1994 Apr; 152(8):3913-24. PubMed ID: 8144960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins.
    Kast WM; Brandt RM; Sidney J; Drijfhout JW; Kubo RT; Grey HM; Melief CJ; Sette A
    J Immunol; 1994 Apr; 152(8):3904-12. PubMed ID: 7511661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class I MHC-peptide interaction: structural and functional aspects.
    Ruppert J; Kubo RT; Sidney J; Grey HM; Sette A
    Behring Inst Mitt; 1994 Jul; (94):48-60. PubMed ID: 7998914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of peptides that bind to the HLA-A2.1 molecule by molecular modelling.
    Lim JS; Kim S; Lee HG; Lee KY; Kwon TJ; Kim K
    Mol Immunol; 1996 Feb; 33(2):221-30. PubMed ID: 8649443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype alleles.
    Matsueda S; Takedatsu H; Yao A; Tanaka M; Noguchi M; Itoh K; Harada M
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6933-43. PubMed ID: 16203785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A alleles.
    Celis E; Fikes J; Wentworth P; Sidney J; Southwood S; Maewal A; Del Guercio MF; Sette A; Livingston B
    Mol Immunol; 1994 Dec; 31(18):1423-30. PubMed ID: 7823968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays.
    Sette A; Sidney J; del Guercio MF; Southwood S; Ruppert J; Dahlberg C; Grey HM; Kubo RT
    Mol Immunol; 1994 Aug; 31(11):813-22. PubMed ID: 8047072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes.
    Alexander-Miller MA; Parker KC; Tsukui T; Pendleton CD; Coligan JE; Berzofsky JA
    Int Immunol; 1996 May; 8(5):641-9. PubMed ID: 8671651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple assay for detection of peptides promoting the assembly of HLA class I molecules.
    Connan F; Hlavac F; Hoebeke J; Guillet JG; Choppin J
    Eur J Immunol; 1994 Mar; 24(3):777-80. PubMed ID: 8125145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC allele-specific molecular features determine peptide/HLA-A2 conformations that are recognized by HLA-A2-restricted T cell receptors.
    Wang Z; Turner R; Baker BM; Biddison WE
    J Immunol; 2002 Sep; 169(6):3146-54. PubMed ID: 12218132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype.
    del Guercio MF; Sidney J; Hermanson G; Perez C; Grey HM; Kubo RT; Sette A
    J Immunol; 1995 Jan; 154(2):685-93. PubMed ID: 7529283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promiscuous Recognition of a Trypanosoma cruzi CD8+ T Cell Epitope among HLA-A2, HLA-A24 and HLA-A1 Supertypes in Chagasic Patients.
    Lasso P; Beltrán L; Guzmán F; Rosas F; Thomas MC; López MC; González JM; Cuéllar A; Puerta CJ
    PLoS One; 2016; 11(3):e0150996. PubMed ID: 26974162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.